Meeting
2023 ASCO Annual Meeting
The impact of the 4R Oncology model on OncotypeDx turnaround time.
Authors
Jenny Wei
Department of Medicine, The Permanente Medical Group, San Francisco, CA
Jenny Wei , Christine B. Weldon , Julia R. Trosman , Zheng Zhu , Elizabeth Shurell Linehan , Amy Ying Ju Lin , Thea Abbe , Lori C. Sakoda , Nancy P. Gordon , Arliene Ravelo , Aida Shiraz , Raymond Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 531)
DOI
10.1200/JCO.2023.41.16_suppl.531
Abstract #
531
Poster Bd #
361
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Adjuvant treatment decisions among women age > 65 with early-stage, hormone-receptor breast cancer seen in multidisciplinary clinic versus standard consultation.
First Author: Sara Rachel Alcorn
Poster
2020 ASCO Quality Care Symposium
Testicular cancer management: Population-wide, rapid case ascertainment to drive early expert engagement and reduced practice variation.
First Author: Andrea Harzstark
First Author: Lisa Barbarotta
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Care delivery and patient self-management for people with primary liver cancer receiving 4R care sequence plans.
First Author: George Therapondos